Gelalens

Market Prices

Coin Price 24h
BTC Bitcoin
$77,194.4 -2.03%
ETH Ethereum
$2,447.12 -3.14%
SOL Solana
$100.22 -2.55%
BNB BNB Chain
$724.3 -0.03%
XRP XRP Ledger
$1.41 -1.09%
DOGE Dogecoin
$0.0825 -2.58%
ADA Cardano
$0.2043 -3.27%
AVAX Avalanche
$7.52 -0.95%
DOT Polkadot
$0.9924 -1.54%
LINK Chainlink
$11.4 -1.56%

Fear & Greed

69

Greed

Market Sentiment

Event Calendar

{{年份}}
30
04
upgrade Celestia Mainnet Upgrade

Improves data availability sampling efficiency

22
03
unlock Optimism Unlock

Circulating supply increases by about 2%

15
04
halving Bitcoin Halving

Block reward reduced to 3.125 BTC

10
05
upgrade Ethereum Pectra Upgrade

Raises validator limit and account abstraction

28
03
unlock Arbitrum Token Unlock

92 million ARB released

08
04
upgrade Solana Firedancer

Independent validator client goes live on mainnet

18
03
unlock Sui Token Unlock

Team and early investor shares released

12
05
halving BCH Halving

Block reward halving event

Altseason Index

42

Bitcoin Season

BTC Dominance Altseason

Gas Tracker

Ethereum 28 Gwei
BNB Chain 3 Gwei
Polygon 42 Gwei
Arbitrum 0.5 Gwei
Optimism 0.3 Gwei

Market Cap

All →
1
Bitcoin
BTC
$77,194.4
1
Ethereum
ETH
$2,447.12
1
Solana
SOL
$100.22
1
BNB Chain
BNB
$724.3
1
XRP Ledger
XRP
$1.41
1
Dogecoin
DOGE
$0.0825
1
Cardano
ADA
$0.2043
1
Avalanche
AVAX
$7.52
1
Polkadot
DOT
$0.9924
1
Chainlink
LINK
$11.4

🐋 Whale Tracker

🔴
0xf472...3a5e
1h ago
Out
747 ETH
🔵
0x7a94...4236
3h ago
Stake
206.47 BTC
🟢
0x6b29...d94f
12h ago
In
7,209,617 DOGE

💡 Smart Money

0xf8b5...5d3f
Experienced On-chain Trader
+$0.7M
60%
0xad1c...f05a
Experienced On-chain Trader
+$3.3M
87%
0xc2df...305c
Market Maker
+$0.9M
93%

🧮 Tools

All →
GameFi

Core Scientific’s $9B Rejection Is a Bet on AMD’s Unproven Stack

PlanBFox

Hook

Shareholders of Core Scientific just voted down a $9 billion acquisition. That’s not a minor disagreement. It’s a signal that the board believes the company is worth more. But the only concrete move they’ve announced since is a partnership with AMD—a chipmaker whose GPU software stack lags Nvidia’s CUDA by a wide margin. No technical milestones. No committed capacity. No revenue guarantees. This isn’t conviction; it’s a leap of faith built on a press release.

Context

Core Scientific is a publicly traded bitcoin miner—ticker CORZ—that filed for Chapter 11 in late 2022 and emerged in early 2024. The company operates roughly 700 megawatts of mining infrastructure across multiple U.S. sites. Post-bankruptcy, management pivoted to a hybrid model: continue mining bitcoin while repurposing existing facilities to host AI and high-performance computing (HPC) workloads. The $9 billion acquisition offer came from an unnamed suitor—likely a private equity firm or a larger infrastructure player—and was rejected by shareholders in August 2025. Days later, Core Scientific announced a partnership with AMD to deploy Instinct GPUs for AI training and inference. The market reacted with a modest price bump, but the details remain sparse. No contract length. No volume commitment. No mention of which AMD chips will be used or how many racks will be deployed.

Core: The Technical Reality Behind the AMD Partnership

Let’s strip away the narrative. Core Scientific’s core innovation is not a new consensus mechanism or a novel Layer 2 protocol. It’s an infrastructure play: converting bitcoin mining facilities into AI data centers. That’s a legitimate engineering challenge, but it’s incremental, not revolutionary. The company’s existing assets—high-power substations, cooling towers, and industrial-scale electrical distribution—are transferable. But the differences between a mining farm and an AI data center are substantial.

  • Cooling: Bitcoin ASICs are air-cooled. AI GPUs, especially high-end models like the AMD Instinct MI300X, require liquid cooling or direct-to-chip cooling. Retrofitting existing facilities adds cost and complexity. Core Scientific has not disclosed how many of its sites are liquid-cooling-ready.
  • Networking: Mining rigs operate on a simple TCP/IP stack. AI clusters require low-latency interconnects like InfiniBand or RDMA over Converged Ethernet (RoCE). AMD’s Instinct platform relies on Infinity Fabric and PCIe Gen 5, but achieving full utilization demands a carefully tuned network fabric. Core Scientific has no public track record in this domain.
  • Software Stack: Nvidia’s CUDA dominates AI development. AMD’s ROCm—the open-source alternative—has improved significantly but still suffers from compatibility gaps and performance penalties in popular frameworks like PyTorch and TensorFlow. Any enterprise deploying AMD GPUs must invest in custom engineering to reclaim performance parity. Core Scientific has not announced any in-house software team for this purpose.

From my experience auditing Layer 2 infrastructure, I’ve seen this pattern before: a company announces a strategic partnership without a technical proof-of-concept. The gap between a press release and a production cluster is measured in quarters, not weeks. Core Scientific’s transition from mining to AI is not a protocol upgrade—it’s a physical rebuild. The company must demonstrate that it can deliver measurable compute capacity—measured in megawatts of AI-ready power, not just hash rate. So far, the only metric is a vague partnership.

Capital Structure and Risk

Core Scientific has no native token. The equity is straightforward: CORZ shares trade on Nasdaq. The rejection of the $9 billion acquisition effectively sets a floor on the company’s perceived value. But that floor is only as strong as the execution. The AI pivot requires significant capital expenditure—new cooling systems, high-density racks, networking gear, and possibly additional GPU procurement. The company’s balance sheet post-bankruptcy is opaque. Public filings suggest a mix of debt and equity, but the exact terms are not materialized in the news. If Core Scientific needs to raise capital, it will likely dilute shareholders through secondary offerings or convertible notes. The $9 billion offer was a cash exit; the current path is a bet on future cash flows, and those flows depend on AMD’s ability to deliver chips and software that compete with Nvidia.

Contrarian: The Blind Spots in the Narrative

The market is treating the AMD partnership as a validation of Core Scientific’s pivot. I see a different dynamic. AMD is the one that needs validation. The company’s data center GPU revenue is growing, but it remains a distant second to Nvidia. AMD needs marquee customers to deploy Instinct GPUs in production environments, generate benchmarks, and prove that ROCm is enterprise-ready. Core Scientific offers a large-scale deployment site, but it also comes with the risk of operational failure. The partnership is likely a two-way bet: AMD provides hardware at favorable terms to gain reference customers, and Core Scientific gets a supply chain alternative to Nvidia. The asymmetry is that Core Scientific’s business model depends on utilization rates. If AMD’s chips underperform or suffer from software immaturity, the GPU clusters will sit idle, and the company’s revenue projections will collapse.

Core Scientific’s $9B Rejection Is a Bet on AMD’s Unproven Stack

Another blind spot: the $9 billion rejection. Shareholders decided that the company is worth more than that. But what if the market is overestimating the speed of the AI transition? The demand for AI compute is real, but it’s also concentrated in a handful of hyperscalers and well-funded startups. Core Scientific is competing with established players like CoreWeave, which already has thousands of Nvidia H100s deployed and a proven track record. Core Scientific’s competitive advantage—cheap power from long-term purchase agreements—is real, but it’s not unique. Many mining companies are pivoting to AI. The market may soon be flooded with HPC capacity, compressing margins. The rejection of the sale could be a value trap, not a value creation event.

Takeaway

Core Scientific’s story is not about blockchain or crypto anymore. It’s about the intersection of physical infrastructure and semiconductor politics. The company’s shareholders have placed a bet that AMD’s GPU stack will catch up to Nvidia’s, and that Core Scientific can execute a complex facility conversion faster than competitors. That’s a high-risk, high-reward thesis. But the absence of technical transparency—no benchmark data, no capacity commitments, no software roadmap—makes this a speculative narrative, not a sound investment.

Core Scientific’s $9B Rejection Is a Bet on AMD’s Unproven Stack

The real question is not whether the partnership is real. It’s whether Core Scientific can deliver results in the next 12 months. If they can deploy 50 megawatts of AI-ready capacity with measurable utilization, the stock will justify the $9 billion rejection. If not, we’ll see a classic case of overpromise and underdeliver—a story that has played out many times in the crypto infrastructure space. I’ll be watching the quarterly filings, not the press releases. That’s where the truth lives.